| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |